Form 4: Cross Country Healthcare Director Receives Stock Grant

Cross Country Healthcare director Janice Elizabeth Nevin was granted 18,680 restricted shares of common stock, vesting on December 18, 2025, following a terminated merger agreement.

Summary

• Janice Elizabeth Nevin, a Director of Cross Country Healthcare Inc. (CCRN), acquired 18,680 shares of common stock.
• The transaction occurred on December 18, 2025, and involved Restricted Stock Awards (RSAs) granted at a price of $0 per share.
• These RSAs are scheduled to vest on December 18, 2025.
• The Compensation Committee of the Company's Board of Directors approved the number of RSAs.
• The grant date for these RSAs was changed from March 31, 2025, to December 18, 2025.
• This change in grant date followed the termination of a Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc., and Aya Healthcare, Inc. on December 3, 2025.
• Following this transaction, Janice Elizabeth Nevin beneficially owns 48,616 shares of common stock.

Sentiment

Score: 5

Explanation: The filing reports a standard compensation event (stock grant) for a director, which is generally neutral to positive for alignment. However, the underlying reason for the grant date change (terminated merger) introduces a negative context, balancing the overall sentiment to neutral.

Positives

• A director receiving a stock grant aligns their interests with those of shareholders, potentially incentivizing long-term performance.
• The grant of 18,680 restricted shares at a $0 price indicates a compensation award, which is a standard practice for board members.

Negatives

• The grant date change was a direct consequence of the termination of a Merger Agreement, which is generally a negative event for a company, indicating a failed strategic initiative.

Risks

• The termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc., and Aya Healthcare, Inc. on December 3, 2025, indicates potential strategic or operational challenges that prevented the merger from proceeding.
• Uncertainty regarding the company's future strategic direction following the failed merger could impact investor confidence.

Future Outlook

The restricted shares granted to Director Nevin are scheduled to vest on December 18, 2025, indicating a future milestone for this compensation.

Management Comments

• The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025.

Industry Context

The termination of a merger agreement, as noted in the filing, can signal a shift in strategic priorities or challenges within the healthcare staffing industry. Such events often lead to re-evaluation of growth strategies and competitive positioning.

Comparison to Industry Standards

• NA

Corporate Governance

Related Party Transactions

• Janice Elizabeth Nevin, a Director of Cross Country Healthcare Inc., received 18,680 restricted shares of common stock as compensation. This is a related party transaction as it involves a company insider.

Stakeholder Impact

• Shareholders: The grant of restricted stock to a director can be viewed positively as it aligns management interests with shareholder value. However, the underlying reason for the grant date change (terminated merger) might raise questions about strategic execution.
• Employees: No direct impact mentioned in this filing.

Next Steps

• The 18,680 restricted shares of common stock granted to Janice Elizabeth Nevin are scheduled to vest on December 18, 2025.

Key Dates

Keywords

CCRN, Cross Country Healthcare, Janice Elizabeth Nevin, Form 4, Insider Transaction, Restricted Stock Award, Stock Grant, Director Compensation, Merger Termination